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ABSTRACT
Among the various "natural laboratories" of high natural or technical enhanced
natural radiation environments in the world such as Kerala (India), Brazil, Ramsar
(Iran), etc., the areas in and around the Central European Ore Mountains
(Erzgebirge) in the southern parts of former East Germany, but also including parts
of Thuringia, northern Bohemia (now Czech Republic), and northeastern Bavaria,
are still relatively little known internationally.
Although this area played a central role in the history of radioactivity and
radiation effects on humans over centuries, most of the valuable earlier results have
not been published in English or quotable according to the current rules in the
scientific literature and therefore are not generally known internationally. During
the years 1945 to 1989, this area was one of the world's most important uranium
mining areas, providing the former Soviet Union with 300,000 tons of uranium for
its military programs. Most data related to health effects of radon and other carcinogenic agents on miners and residents became available only during the years after
German reunification. Many of the studies are still unpublished, or more or less
internal reports.
By now, substantial studies have been performed on the previously unavailable
data about the miners and the population, providing valuable insights that are, to
a large degree, in disagreement with the opinion of various international bodies
assuming an increase of lung cancer risk in the order of 10% for each 100 Bq/m3
(or doubling for 1000 Bq/m3), even for small residential radon concentrations. At
the same time, other studies focusing on never-smokers show little or no effects of
residential radon exposures. Experiments in medical clinics using radon on a large
scale as a therapeutic against various rheumatic and arthritic disease demonstrated
in randomized double-blind studies the effectiveness of such treatments.
The main purpose of this review is to critically examine, including some historical
references, recent results primarily in three areas, namely the possible effects of the
inhalation of very high radon concentrations on miners; the effect of increased
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residential radon concentrations on the population; and the therapeutic use of
radon. With many of the results still evolving and/or under intense discussion
among the experts, more evidence is emerging that radon, which has been inhaled
at extremely high concentrations in the multimillion Bq/m3 range by many of older
miners (however, with substantial confounders, and large uncertainties in retrospective dosimetry), was perhaps an important but not the dominating factor for an
increase in lung cancer rates. Other factors such as smoking, inhalation of quartz
and mineral dust, arsenic, nitrous gases, etc. are likely to be more serious contributors to increased miner lung cancer rates. An extrapolation of miner data to indoor
radon situations is not feasible.
Concerning indoor radon studies, the by far dominating effect of smolung on the
lung cancer incidence makes the results of some studies, apparently showing a
positive dose-response relationship, questionable. According to recent studies in
several countries, there are no, or beneficial, residential radon effects below about
600 to 1000 Bq/m3 (the extensive studies in the U.S., in particular by B. Cohen, and
the discussions about these data, will not be part of this review, because they have
already been discussed in detail in the U.S. literature). As a cause of lung cancer,
radon seems to rank - behind active and passive smoking, and probably also air
pollution in densely populated and/or industrial areas (diesel exhaust soot, etc.) as a minor contributor in cases of extremely high residential radon levels, combined
with heavy smoking of the residents.
As demonstrated in an increasing number of randomized double-blind clinical
studies for various painful inflammatoryjoint diseases such as rheumatism, arthritic
problems, and Morbus Bechterew, radon treatments are beneficial, with the positive
effect lasting until at least 6 months after the normally 3-week treatment by inhalation or bathes. Studies on the mechanism of these effects are progressing. In other
cases of extensive use of radon treatment for a wide spectrum of various diseases, for
example, in the former Soviet Union, the positive results are not so well established.
However, according to a century of radon treatment experience (after millenniums
of unknown radon therapy), in particular in Germany and Austria, the positive
medical effects for some diseases far exceed any potential detrimental health effects.
The total amount of available data in this field is too large to be covered in a brief
review. Therefore, less known - in particular recent - work from Central Europe
has been analyzed in an attempt to summarize new developments and trends. This
includes cost/benefit aspects of radon reduction programs. As a test case for the
LNT (linear non-threshold) hypothesis and possible biopositive effects of low radiation exposures, the data support a nonlinear human response to low and mediumlevel radon exposures.

Key Words: radon, radiation risks, LNT hypothesis, lung cancer, radon balneology.

HISTORY OF RADON EXERIENCE AND RESEARCH IN CENTRAL EUROPE
Observations of beneficial radon effects on human health may reach back into
pre-historic times, as there are archaeological indications that the radon sources in
Gastein, Austria, have already been used many thousand years ago (Deetjen 1999).
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The use of radon-containing springs for health reasons in such different civilizations
as ancient Rome, medieval Japan, and Central Europe has been documented for
hundreds or thousands of years without any knowledge of radon.
The modern history of radioactivity and radon may be traced back to the mining
activities in the mountain range between Saxony and Bohemia southwest of Dresden,
where in 1168 Freiberg silver ore was accidentally discovered, which became the
basis for the largest silver mining activities in Europe during the 13"' century, in
particular after additional discoveries in 1470 in Schneeberg. In 1481, Schneeberg
already had 153 mines, and the rich profits permitted relatively advanced mining
technologies, reaching a depth of about 400 m. More silver was found in 1497 in the
nearby city of Annaberg, and in 1516 in St. Joachimsthal on the Bohemian side of
what by now was known as the "Erzgebirge" (Ore Maintains), indicated in Figure 1
in a "radon map" of Germany.
The silver minted there became known as the "Joamchimsthaler", abbreviated later
into "Thaler", and anglicised into "Dollar". When the mines became exhausted and
abundant silver available easier in Latin America, mining continued for cobalt (providing, the blue color for the famous Meissen porcelain), bismuth, nickel, tungsten,
arsenic, as weH as uranium, used, for example, in the green-yellow fluorescent uranium glasses. Therefore, this area had already a half millennium tradition of continuous mining before, in 1946, the Soviet rush for uranium made this area the "Klondike
in the Ore Mountains" (Paul 1991; Becker 1992) and, with a total output of 220,000
tons of uranium until 1989 when East Germany ceased to exist and the nonprofitable
production was stopped, one of the world's main uranium sources.
Several elements have been discovered in this area, including germanium and, in
1789 the Berlin chemist Klapproth discovered uranium (for a review see Schuttmann
1989). From the local mineral "Pechblende" came the uranium in which Becquerel
discovered radioactivity,and Hahn and Strassmann in 1938 in Berlin nuclear fission,
as well as the Curies in Paris in 1898 polonium and radium. After E. Rutherford
found that thorium emitted a radioactive gas that he called "emanation", Dorn in
HaHe, Germany, found a similar emission from radium, and two other German
scientists (J. Elster and H. Geitel, Wolfenbuttel) identified both gases as normal
constituents of the atmosphere, resulting from the radium content in the Earth's
crust (for further historical references see Schuttmann and Aurand 1991).
In 1902,JJ. Thompson discovered in Cambridge/England that "emanation" was
also part of the local water. In Bad Gastein, Austria, the physicist Mache from the
Vienna University (after whom the first unit for radon concentrations was named)
tested 15 natural springs and found varying, but in some cases very substantial
concentrations of "emanation". Together with his colleague Meyer, he later investigated other spas in Austria and Bohemia, and reported in 1905 also high concentrations in the waters and air in the uranium mines in Joachimsthal, which was the
first reference to underground radon. In 1907, H. W. Schmidt, University of GieBen,
Germany, reported high radon concentrations in residences (for further details see
Schiittmann 1986, 1990, 1992, 1994, 1997a).
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Figure 1.

Distribution of radon air in top soil in Germany. Areas in black indicate more
than 500,000 Bq/m" in white less than 50,000 Bq/m3, and circles around the
main uranium mining areas Schneeberg/Schlema (after Radon-Handbuch
Germany Figure 2.1, 2001).
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Preceding the discovery of what is now known as radon (usually including in this
term the various daughter products that are more or less in equilibrium with radon,
assuming usually an F-factor of about 0.4) and its beneficial health effects, there
have also been observations of detrimental health effects among miners in this area.
First indications date back to around 1485 to 1490, when A. P. Schneevogel mentioned "dangerous air in the depth of the earth". About 1530 the famous physician
Theophrastus Bombastus von Hohenheim (called Paracelsus) wrote a book published after his death in 1567 (Paracelsus 1925 edition). Already in 1473, U. Ellenbog
and in 1529, M. Hunt (Leipzig, Saxony University) published warnings for miners
concerning what was called "Bergsucht" (mountain disease), as a summary description of all sorts of pulmonary problems affecting miners. However, it was Paracelsus
who first brought this disease to wider attention.
Among his many insights in medical history are "It is the dose which makes the
poison", and "I believe only in what I found myself, and was confirmed by long
experience". Another famous name associated with the early history of miner's lung
diseases is that of G. Agricola (latinized for Georg Bauer), also from Saxony (1494
to 1555), who wrote basic books about mining and metallurgy, and also mentioned
lung diseases among the miners in various European countries due to "bad vapours"
in mines caused by the lack of ventilation (Agricola 1928 edition; also see Menzel
1989; Schiittmann 1994).

RADON AND LUNG CANCER IN MINERS
The disease "Bergsucht" was, lacking modern medical diagnostics, a summary
expression for pneumonia, acute and chronic bronchitis, lung emphysema, tuberculosis, silicosis, and other mineral dust-related problems. It was in the Schneeberg
region of Saxony that these, at those times already world-wide common miner's
diseases, were first studied. They led, after shortness of breath etc., to a relatively
early death. In the 19th century, it became known as "Schneeberg lung disease" or
"Schneeberg mountain sickness". In 1879, two local doctors reported in detail that
this disease was a malignant process that became known as "Schneeberg lung
cancer" (Hartling and Hesse 1879). Originally assumed to be a lymphosarcoma, it
was later identified as bronchial carcinoma. As a possible cause, the high content of
arsenic, but also toxic metals such as cobalt, nickel, bismuth, and quartz dust were
considered. Only after the discovery of ionizing radiation, "emanation" also became
a suspect, and was in 1913 first associated with the high lung cancer rates by the
mining inspector H. E. Schmidt from Zwickau, Saxony (for a historical review see
Schiittmann 1988).
Later epidemiological studies on miners exposed to very high radon levels
(between 7.6 Working Level Months (WLM) in Radium Hill and 580 WLM in
Colorado) in various countries, including China, France, Sweden, Canada, Czechoslovakia, and the U.S., led to the "meta-analysis" of such studies (Lubin et al. 1994),
which was the basis of the semiofficial risk assumptions in the BEIR reports (BEIR
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VI 1999). It assumed radon to be the key reason for miner lung cancer despite some
remarkable inconsistencies. For example, the excess relative risk (ERR) per WLM,
which should have been rather uniform assuming radon as the main cause and a
linear dose-response relationship, varied between 0.0016 in China and 0.051 in Port
Radium, or by a factor of almost 30.
Nevertheless, data like those obtained in Bohemia, became the basis of further
regulatory activities. Other investigations project a different image. For example,
the "forgotten doses" among miners may have resulted in an underestimate of the
actual dose (and corresponding overestimate of residential doses) by a factor of
about three (Duport 2002), and other estimates of the radon to miner's lung cancer
(Conrady, contribution unpublished) amount to a contribution of only around 7%
of the radon to the total of additional miner lung cancers.
Very high radon concentrations have also been observed in non-uranium-mining
underground activities, for example, mineral and coal mines (e.g., in Poland),
guides in natural caves open to visitors in various countries. There are high overground
radon professional exposures, for example, in public water supply facilities. In the
"clean water hall" of a plant in Hof, Bavaria, perhaps the world record of about
750,000 Bq/m3 in air has been measured repeatedly (e.g., Becker et al. 1992). Even
values above 1 MBq/m3 occasionally occurred. The situation is similar in the water
storage facilities of hundreds of other German not only in Bavaria, using water from
formations with a high natural uranium content. For example, in Eastern Bavaria
the annual radon exposure of 11% of the water supply employees (assuming current
ICRP values) presently exceeds the legal 20 mSv/y limit for radiation workers (Miick
2002).
According to BEIR VI, smoking increases the lung cancer risk by a factor of 10
to 20 and radon by 0.2 to 0.3, which implies a smoking risk about 50 times higher
than the radon risk. Miners are known to have smoked more than the average
population. In the Schneeberg area, the miner's smoking rate in the early uraniummining period, also called the "wild years" (1946 to 1954), has been estimated to
have been above 90%. Moreover, uranium miners (many of them forced laborers)
received, in compensation for extremely unpleasant and dangerous work, large
rations of cigarettes and cheap liquor for the normal population smoking was in the
starvation situation of the Soviet occupation zone of Germany in the post-WWII
years an unaffordable luxury but almost all miners were heavy smokers inside as well
as outside the mines. In nearby former Czechoslovakia, the situation was similar.
The correction of epidemiological data for the by far dominating factor of
smoking is complicated by the fact that smokers notoriously underestimate (even
more than alcohol and drug addicts) their actual cigarette consumption, in particular after a lung disease has been diagnosed. Thus, "retrospective smoking dosimetry"
with selfestimates covering several decades, or based on unreliable memories of
relatives, are subject to substantial uncertainties, which may explain in part the wide
fluctuations between 0.2 and 5.1% per WLM in radon risk estimates (see, for

Nonlinearity in Biology, Toxicology, and Medicine. Vol. 1, No. 1, 2003

https://scholarworks.umass.edu/dose_response/vol1/iss1/2

6

Becker: Health Effects of High Radon Environments in Central Europe
Health Effects of High Radon Environments in Central Europe

example, Suidicani and Hein 199'1; Conrady et al. 1999). Smoking itself produces,
as was first pointed out in Germany (Rajewski and Stahlhofen 1966), an alpha
radiation exposure to the bronchial tract due to the polonium-210 content in
tobacco, but this has not to be considered a health hazard compared with the other
smoking effects (Cross 1984).
Among other complicating factors in the correct assessment of miner radon risks
are
1. Large uncertainties in the retrospective estimates of radon exposures in mines
at times before individual radon dosimetry, with concentrations known to be
subject to high fluctuations with time and location, depending on ventilation
and other factors. There is, however, sufficient evidence that the concentrations frequently exceeded 2 MBq/m3 (or about 2 Sv/y according to ICRP).
Other estimates (Kreuzer et al. 2002) assume in the East German uranium
mining area, for example, in 1955, 'median exposures of 120 (upper 75%
quartil 200) WLM/y. According to a recent study involving 48,000 former
uranium miners, about 500 cases of lung cancer matched with 1000 controls,
with only 9 never-smokers among the miners and 165 anlong the controls, up
to at least 800 WLM no radon effects have been found (Briiske and Hohlfeld,
to be published).
2. Confounding effects such as diesel exhaust fumes, nitrous gases from blasting,
dust effects due to dry drilling, etc. It also became known that "hidden doses" due
to external gamma radiation, inhaled radioactive ore dusts, very different equilibrium factors, etc., contribute as much or more to the miner exposure and may
increase the actual doses by a factor of up to three. Miners may also have been
exposed to other carcinogens during other parts of their professional life and/
or lived in high radon houses (Duport 2002).

3. Basic problems in the dose calculations, for example, because of uncertainties
in the lung models (there is a difference in the effective dose estimates for
radon between two consecutive ICRP reports by a factor of about three), and
in the radiobiological effect (the "official" name for it continues to change) for
alpha particles, assumed by ICRP to be 20. To quote from a recent EU
publication: "An analysis of lung cancer deaths in uranium miners leads to an
RBE for alpha particles of 5 to 10, depending on which cells are regarded as
targets" (Edwards 2001). Careful animal inhalation experiments in the U.K.
with differently spiked aerosols demonstrated an RBE for inhaled nuclides of
2, which is a factor of 10 less than the current ICRP recommendation of 20
(Kellington et al. 199'1).
4. Obviously, the role of the exposure rate has been vastly underestimated. It has
been shown in animal experiments at high radon levels that the time distribution of the dose is equally or even more important than the WLM dose (Monchaux
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and Morlier 2000; Monchaux 2001). They found that the lung cancer rate in rats
exposed at low rates was actually lower than in the controls. These experiments
continue in cooperation with British and U.S. scientists.
In Germany, there are currently two studies about radon effects on miners in
progress. One casecontrol study for the Federal Institute of Worker Protection and
Medicine has been primarily completed, with more detailed follow-up studies perhaps
to follow. According to such studies, only about 7% of the lung cancers among
uranium miners may be related to radon (Conrady et al. 2000). T o
quote from the abstract: "Radiation exposure did not determine predoininantly
the lung cancer risk. In its relative significance, smoking is first, followed by quartz dust
at second position. At third follows arsenic, and at fourth position radon with its
daughters."
The other study by the Institute of Radiation Hygiene of the Federal Radiation
Protection Office (Kreuzer et al. 2002) is still in progress, with a sample s i ~ of
e about
60,000 miners (out of a database of 130,000),and a similar nuinber of controls. *I'IICS
miners have been classified into three periods of the Soviet uraniulii ~iiiiiiiig( i l l 4 0
known as Wismut AG):
1. "the wild years" 1946 to 1954 (Becker 1992) with very high dust and radon
exposures and essentially n o protective measures. During this period, radon
levels have been estimated to exceed frequently 2 million Bq/in3 in the mines;
2. a transition period with better ventilation, introduction of dust-reducing wet
drilling, etc.; and

3. introduction of simple radon measurements and approaches to internationa1
standards after 1971, until the end of the mining activities in 1989.
The evaluation of the data, which have been mostly kept secret until the collapse
of East Germany, will probably be completed in 2003. Special efforts are being made
to consider the main confounders smoking and arsenic.
There seems to be no doubt that radon contributes to some degree to the
increased lung cancer rate among uranium miners, but several questions remain
open in the common approach to extrapolate miner data over orders of magnitudes
down to the completely different residential radon situation, in particular: how are
the epidemiological miner data; how important is the role of radon compared to the
confounders; and what are the consequences of the completely different working
conditions of the miners? Among the many differences between miners and home
residents, as already pointed out years ago (e.g., Schiittrnann 1997), many factors
have to be considered, such as:
1. the very different dose levels and dose rates;
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2. the underestimation of the miner exposures, e.g., due to radioactive dust,
external gamma exposures, and sometimes unusually high additional residential exposures (e.g., Duport 2002);

3. neglecting the above-mentioned confounders, and the so far little known
synergistic interactions;
4. differences in the lung characteristics between miners and residential populations depending on age and sex, the structure of the bronchial system, localization of the target cells, and condition of the mucocilear clearance;

5. differences in the breathing function (e.g., frequency, volume, ratio mouth to
nose breathing); and
6. breathing air characteristics (aerosol properties and size distribution, radon to
daughters equilibrium, contribution of unattached daughter products, etc.).
Another factor that has widely been neglected in considering miner lung diseases
is the occurrence of lung fibrosis, which should not be confused with cancer,
emphysema, and other lung problems. This complex topic has been well described
(Arndt 1994) with numerous references to human and animal data. They show the
synergistic effect between the inhalation of uranium containing and other mineral
dusts as well as other dangerous gases and aerosols and radon exposures. There are
various parameters besides radon exposures, including increased uranium and
thorium excretion in urine, and autoradiographic or body-counter determination
of long-lived radon daughter products such as polonium-210 in the skeleton, which
could lead to additional information beyond the limited dosimetric relevance of
radon lung exposures.
Also to be considered is the actual hit probability for stem cell nuclei in the
bronchial epithelia for alpha exposures. Obviously, even within the dose limit for
miners, the probability of a nucleus being hit is extremely small, and most of the
cells experience n o hit during the human lifetime. More information on the
radiation response of the lung can be found in the proceedings of a symposium in
Germany (Herrmann et al. 1994). Further interesting evidence regarding radiationinduced carcinoma in the human lung have been provided, for external X and
gamma exposures with a threshold of ca. 2 Gy (Rossi and Zaider 1997),for inhaled
plutonium oxide (Tokarskaya et al. 1997) of 0.8 Gy (16 Sv according to ICRP), and
for radium incorporation by dial painters of 10 Gy, corresponding to 200 Sv (!)
according to ICRP (Rowland 1995).
It is obvious that, for the reasons outlined above, a linear transfer from the
conditions in mines over orders of magnitude down to normal residential levels is
not feasible. Concerning miner exposures, the informal consensus among the
experts currently is that there is no lung cancer hazard below 500 to 1000 WLM.
However, the important question of a possible extrapolation from miner data to
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indoor radon effects is still a subject of studies and controversies in Central Europe,
as some epidemiologists continue to claim consistency between miner and indoor
data.

INDOOR RADON AND LUNG CANCER
The first measurements of increased indoor radon levels were carried out in
Joachin~sthalat the German/Czech border by H. W. Schmidt from Giessen in 1907,
followed by many other measurements in other locations in and around Gernlany.
In 1948 measurements of the radon concentration in the Bad Schlema outdoor
atmosphere (about 365 Bq/m 3), houses (3,200 Bq/m3), and soil air (150,000 Bq/
m 3 ), which had been obtained since 1944, were published together with a map
showing the radon distribution in this city (Krebs and Lamper 1948). In 1956, in
Sweden very high values were measured in buildings for which alum shale with a
high natural uranium content had been used as a construction material (Hultquist
1956). In the U.S., health officials found out in 1966 that in and around Grand
Junction, Colorado, around 1950 to 1965 large amounts of sand-like tailings from
uranium extraction had been used for the construction of homes, schools, and
other public buildings, leading to elevated indoor radon levels. The practice was
stopped and an extensive remediation program initiated.
This triggered a surge of scientific and public interest in the residential radon
issue, spilling over from the U.S. and Sweden to other countries, as described in
detail in "Element of Risk: The Politics of Radon" (Cole 1993). For example, in the
New York Times, in the peak year of 1987, articles about radon appeared, and one
specialist,J. Harley, accumulated a total of 2500 articles on this subject (by now, this
number probably exceeds 5000, making it impossible to cover them comprehensively in a review like this). V. J. Houk, Asst. Surgeon General of the U.S. Public
Health Services, declared in 1988 that "radon-induced lung cancer is one of today's
most serious public health issues", and a commercial Advertising Council, Inc., was
hired by EPA to promote, at great expenses to the taxpayer, the "EPA Radon
Awareness Program". Such EPA efforts still continue in the U.S., as well as in other
countries; however, with only limited success (Marcinowski 2002).
E. Letourneau, then Director of the Canadian Radiation Protection Bureau,
statedthat in 1991 seven countries had adopted or proposed indoor radon standards, namely, Canada, Finland, Germany, Norway, Sweden, the U.K., and the U.S.,
and noted that "radon is a disease which spreads from the north.. .. The geographic
configuration is related to the luxury of worrying about risk that most countries do
not feel is worth to worry about." He also remarked that "radon is an artificial
disease, created by the multiplication of a very small risk with large populations, in
order to create frightening numbers" (Letourneau 1987).
Many similar statements could be added. SCIENCE wrote in an Editorial (Abelson
1991), that "EPA continues to assert that radon is a major cause of lung cancer
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fostering a radon program that could entail huge financial and emotional losses
while yielding negligible benefits to public health." W.G. Mills, then president of the
Health Physics Society, wrote to the author in 1993: "Fortunately, the general public
is not buying EPA's activist efforts, and only the U.S. Congress and those in the
radon business keep the "hazard" alive". This statement is still true, in particular if
personal expenses are involved. In many high-radon areas in Western Europe
despite expensive radon-warning campaigns, an increasing number of people refuse
even free-ofcharge governmental radon measurements as an unwanted and unnecessary intrusion into the privacy of their homes.
Already about a decade ago the U.S. Health Physics Society criticized the EPA
assumption that indoor radon causes about 20,000 lung cancer deaths annually in
the U.S., promoting remediation measures that would cost the U.S. citizens $8 to 20
billion, with a 1988 Indoor Radon Abatement Act requiring the long-term national
goal that all buildings "should be as free of radon as the ambient air outside the
buildings". Some scientists pointed out that, if technically feasible at all, the cost
could be $1 trillion (unless, of course, all U.S. citizens would decide to live in tents,
tree houses, or on rafts). Such intensely promoted programs in the U.S. also
influenced the recomn~endationsof international organizations, and expensive
radon survey and reduction policies in Europe (Becker 2001).
According to the latest, yet unpublished reports, the currently recommended EU
limits of 200 Bq/m3 for new and 400 Bq/m3 for new houses, are substantially
exceeded in many countries. For example, in Sweden, about 150,000 dwellings (4%
of the total) exceed the 400 Bq/m3 limit, in Southern Tyrol/Italy lo%, and in the
Czech Republic 2 to 3% of all buildings (in some areas more than 20%).Switzerland
established legal limits of 400 for new and 1000 Bq/m3 for old buildings. This is
close to recent suggestions of ICRP, namely, 500 Bq/m3 at home and 1000 at the
working place, but in conflict with the regulations in the EU.
It has been estimated in various official and semiofficial reports and recommendations that residential radon probably is, far behind smoking, the second most
important cause of lung cancer. There is, however, increasing evidence that this may
not be true because most of the so-called "radon effects" are actually directly related
to smoking. Even passive smoking and the inhalation of polluted air in industrialized areas, soot from diesel engines (big cities, heavy construction vehicles, truck
drivers, etc.) create a higher risk, also regarding other types of cancer.
In essentially all industrialized countries, in particular in Western Europe, more
or less comprehensive residential radon screening programs have been carried out
by governmental agencies. Hundreds of publications are by now available on this
subject, involving even such unlikely locations as kindergartens in Slovenia, hospitals in England, Greek Caves and wine cellars in Germany. This avalanche of data
is closely related to the fact that radon in buildings is relatively easy (but not always
accurately) measurable by the method of alpha particle track etching in organic
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polymers. Many areas in various countries have, by expensive screening programs,
been identified with high and low concentrations. The average radon levels in
Finland far exceed those in the Netherlands, and there are areas such as Cornwall
in the U.K., or (former) uranium mining areas in Germany and Czechia well above
the country average.
In earlier years, activated carbon detectors and electronic nonintegrating devices
have been used, but turned out to be not sufficiently accurate due to the well-known
very substantial fluctuations orders of magnitude, depending on the daily ventilation cycles, annual seasons, exact location in a house, wind direction, etc. (see, for
example, Miles 2001). Therefore, long-term radon integrating detectors, based on
the method developed by the author decades ago (Becker et al. 1968; Becker 1969),
are, usually for a 3 to 12 month period, most widely used in differently designed
devices with different polymers and evaluating techniques.
In Europe, small chambers containing the polymer that have been refined by the
NRPB in the U. K., the SSI in Sweden, the Karlsruhe Research Center in Germany,
and by several private companies in Sweden, Germany, and Hungary, are particularly popular. They undergo frequent quality control tests under carefully controlled laboratory conditions. However, they do not reflect the actual in situ precision. Nevertheless, results are frequently reported as three- to fourdigit numbers,
thus suggesting high accuracy when even the first digit may be rather questionable.
Current costs for a reasonably reliable 3-month test are around $10 to 20 U.S., and
for the currently popular tests in schools and kindergartens, about $100 U.S. are
assumed.
More recently, electronic integrating devices as well as "retrospective" methods,
e.g., based on the measurements of alpha tracks in CR 39 of eye glasses, or of lead210 with polymers on the surface of glass of known age (such as the inside of house
window and picture glasses) are also being used. The results are reliable within
about 30% under controlled conditions, but may vary more in practical situations
involving wider fluctuations in the equilibrium between radon and daughters, and
changes made in the house. Long-term residential radon exposure estimates remain
subject to substantial errors.
As a typical result of one of the many comprehensive radon surveys, a map of
Germany in Figure 1 shows the radon activity in ground air with a high resolution.
Obviously, it varies between as much as over 500,000 Bq/m3 in some areas of Saxony
and Bavaria, and less than 10,000 Bq/m3 in other parts (Kemski et al. 1999). Those
data may to a large degree (but not completely) be correlated to the radon concentrations in ground-floor living rooms (Figure 2).
During the last decade, a well-known worldwide discussion about the lung cancer
risk due to radon in homes as well as in other overground facilities such as working
places in water supply facilities, schools, and other public buildings took place. Only
a few relevant points can be mentioned within the limited scope of this review. An
ongoing argument concerns the relative merits of different epidemiological meth-
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Figure 2.

Average of the radon in the ground floor of living rooms of communities in
Germany (black above 400 Bq/m3, white less than 100 Bq/ms) (Siehl 2000).

ods to assess residential lung cancer incidence, in particular the "ecological", the
casecontrol, and the cohort studies, which all have advantages (such as large
numbers of cases) as well as disadvantages (time, costs, role of confounders, statistical power).
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In a recent review, it is concluded that current controversies about radiation risk
estimates based on epidemiological studies are due to diverging data interpretation,
with over- and underestimates of the significance (power) of the studies frequently
leaving the scientific basis, with a detection limit for relative additional risks around
20% (Breckow 2002). A comparative analysis of 18 case-control studies in Russia
(Yarmoshenko 2002), with "weighting factors" given to their reliability, resulted in
a U-shaped response curve, and there is evidence from studies in Germany that
moderately increased radon levels also reduce other types of cancer, including
leukemia.
The well-known and muchdiscussed comprehensive studies by B. Cohen in the
U.S., which have been confirmed by several other studies there, have also been
confirmed in Central Europe. According to the ICRP estimates, lung cancer among
the (largely never-smoking) females in the former Soviet uranium mining areas in
East Germany should have been much higher than the actual cancer register shows.
In one of the highest radon areas (district of Gera), the observed values were among
the lowest the whole country. Comprehensive measurements in the high radon
areas, combined with remediation measures, amounted to total costs to the German
government of about $2000 million U.S. (Becker 1996). For example, in the old
mining town of Schneeberg near Schlema, the average radon concentration in
homes was 290 Bq/m3, or twice the limit of the U.S. EPA; 13% exceeded 1000 and
over 1% 15,000 Bq/m"with a maximum of 115,000 Bq/m 3). Those were essentially
the same houses in which n o lung cancers had been detected in careful studies
decades earlier (Saupe 1928).
In fact, the expected: on the basis of the country average, not the ICRP assumptions, cancer cases among the females in the high radon areas between 1983 and
1987 are lower and not higher than the country average (Table 1 and lc). Obviously,
the residential lung cancer rate is inversely proportional to the radon concentrations.
With increasing radon values, the number of observed cases actually appears to
decrease and not increase, as predicted by ICRP, with increasing radon levels
(Table l c ). A study involving the lung cancer registry of East Germany between 1960
and 1988 (Conrady et al. 1996) has been summarized by the authors as follows:
"No relation between residential radon exposure and the cancer risk in general, or
lung cancer risk in particular, could be detected in the ecological analysis of regions,
counties, and communities."
Similar results have also been reported from other countries such as Austria
(Friedmann 2002). In different states with annual average population exposures
between 47 and 136 Bq/m3, according to ICRP 65 there should have been annual
lung cancer casualities between 5.7 and 16.5 per 100,000 (a factor of about 3), but
it was in fact lower in the highest than in the lowest radon regions. Looking just at
the female cases, in one region (Oberosterreich) there should have been 60% more
"ICRP estimated radon cases" than were totally observed.
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Table 1. (a) Observed cases of female lung cancer in high residential radon
areas in Saxony compared to expected values on the basis of the East
German average (data from Arndt 1992). (b) Observed and expected
cases among nonsmoking females in high and low residential radon
areas in Saxony, all age categories 1961-1989 (data from Conrady et
al. 1996). (c) Percentage of observed cases according to the
population average, and to the ICRP model (data from Schiittrnann
and Becker, unpublished).

Table la
County
Aue (including Schneeberg)
Annaberg-Buchholz
Schwarzenberg
Klinnenthal
Total

Observed
37
11
10
9
67

-

Expected
45
31
20
15

111

Table 1 b
Indoor radon level
(~qm-~)
< 100
100 - < 250
150- < 500
> 500
Total

Observed cases

1251
374
152
378
2155

Expected cases
(population average)
1202
400
157
443
2202

Eicpected cases
(ICRP model)
1477
492
255
975
3199

Table 1c
Radon range (Bq/m-l)

Percentage of population
average

Percentage of ICRP model

< 100
100 to < 250
250 to < 500
> 500
Average

It is believed among epidemiologists that casecontrol studies are less subject to
confounding factors and thus more reliable. The most widely quoted "meta-analysis"
of eight such studies in several countries in Europe, the U.S., and China show about
30 data points with very large vertical and no horizontal error bars (Figure 3), with
only one or two slightly above the zero line. Even for the 450 Bq/m3 Swedish data
point, the same group has recently shown that, with a different evaluation method,
this "positive" result can be transformed into a "negative" one (Legarde et al. 1997).
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A recent study from the Swedish Radiation Protection Authority (formerly SSI)
(Mjijnes and Folk 2002) finds that the lifetime lung cancer risk for smokers at 1000
Bq/m3 (seven times the EPA limit) is 25%, but less than 10% (with a background
level of about 3%) for never-smokers. The authors conclude that "most of the radonrelated lung cancers, perhaps as much as 90%, occur among smokers". This appears
to confirm the observation of Schtittrnann (1999) that residential lung cancer was
essentially nonexistent before large-scale cigarette smoking commenced in Central
Europe during the second half of the lgt" century.
In a detailed review summarizing the results of 12 different studies) the residential radon risk among non-smokers (Neuberger and Gesell 2002) came, even without considering the above new data, to a very similar conclusion, namely, that "most
of the studies did not find ally significant association between radon and lung
cancer in non-smokers. .. Based on the most recent findings, there is some evidence
that radon may contribute to lung cancer risk in current smokers in high residential
radon environments". Obviously, the evidence converges into a simple conclusion:
Better not to smoke if one happens to live in a house at more than 1000 Bq/m3.
The intense efforts in the accumulation of more data in casecontrol studies
continue (Kreienbrock 2002). So far, a total of 17 studies have been completed, and
10 more are under evaluation. Some of them seem to indicate a slight increase in
the odds ratio with increasing radon levels (Figure 4), in reasonable agreement with
ICRP and BEIR VI estimates of the lung cancer risk doubling with an increase of
1000 Bq/m3, but others show quite different results. However, even the authors of

A New Jersey X FmnJand l

Stockholm HSchweden UWlnnipeg 0 Missouri A Finnland ll

0.26

Figure 3.

Relative lung cancer risk as a function of residential radon according to a metaanalysis of case-control studies in various countries (modification of Figure l ,
p. 52, Lubin and Boice 1997).
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this study state in another publication (Kreuzer et al. 1998) on lung cancer in young
adults that "radon was not considered a risk factor, because it is a weak risk factor.
To detect a risk, big sample sizes and a high prevalence of radon are needed."
An EU-supported international study (Conrady et al. 1999) clearly shows, contrary to the above study and in clear disagreement with the ICRP/BEIR VI LNT
model, among nonsmoking women a threshold for residential lung cancer around
1000 Bq/m3 (Figure 5). These and further results (Conrady et al. 2001) are in good
agreement with the data for nonsmoking women in the Chinese Sheniang study,
indicating an initial decrease with increasing radon concentration, followed by an
increase above approximately 1000 Bq/m3 (Figure 6).
The most likely explanatioil of such different results in an area of high statistical
uncertainties appears to be the underestimated effect of the dominating role of
cigarette smoking in human lung carcinogenesis. It is not only of historical interest
that, at a time when this type of cancer was already well known in Saxony due to the
miner diseases, lung cancer was extremely rare in the population, with essentially
every single case reported in a scientific publication or an M.D. thesis. Approxi-

Radonkonzentration in Bqlcbm

Figure 4.

Lung cancer risk as a function of residential radon levels (Bq/m3): estimated
odds ratio and 95 % confidence intervals according to the "East German Radon
Study". (Reproduced from Wichmann et al. 1999, used with permission of

Ecomed and the editor.)
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- Schneeberg
LNT

Figure 5.

The relative lung cancer risk as a function of residential radon levels (Bq/ms)
according to ICRP (LNT hypothesis-straight line), the "German radon study"
by Wichmann et al. (1998, 1999), and the "Schneeberg study" (lower line) by
Conrady et al. (1999).

Figure 6.

Odds ratio for lung cancer as a function of residential radon concentration (Bq/
m3) among nonsmoking females in the Schneeberg Study, compared to the also
nonsmoking females in the Sheniang study. (Reproduced from Conrady et al.
2003, Proceed. 3. Biophysikal. Arbeitstagung Schlema 2001, registered with the
Germail Library in Frankfurt, ISSN 1610-5079, used with permission of RADIZ.)
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mately 20,000 autopsies have been performed since 1852 in Saxony's largest hospital
in the capital of Dresden. The lung cancer rate rose from only 0.06% between 1852
and 1876 to 0.21% from 1877 to 1884. Between 1885 and 1894, it increased to
0.43%, and currently is almost 10 times higher. It is probably n o coincidence that
Germany's first cigarette factory had started production in Dresden in 1862
(Schiittmann 1999).
The overwhelming effect of the confounder smoking on radon epidemiology has
been summarized recently in a paper "The true size of lung cancer risk from indoor radon:
Hidden behind a smoke screen?" (Conrady et aL. 2003; see also Becker and Field 2001;
Becker and Schuttmann 1998; and Becker and Wichmann 2002). It is not likely that
further meta-analysis work, including new casecontrol studies, as they are currently
in progress in Canada and the U.K., will be able to overcome this problem. The main
reason is the retrospective assessment of smoking habits, in particular after lung
cancer has been found.
Even more than in alcohol and drug abuse, it has been shown that smokers especially after diagnosis of a lung disease - vastly "underestimate" their past and
present smoking behaviour, thus making it de facto impossible to establish radon
effects by epidemiology in populations with a high percentage of smokers. It has
been shown that an underestimate of only one cigarette/day could falsify some of
the casecontrol radon studies on which "official" risk estimates are currently based.
Because of its great fundamental and economic importance, the discussion about
the relative merits of different epidemiological studies continues (see, for example,
Mossmann 1998; Breckow 2002).

THERAPEUTIC USES OF RADON
Sources now known to have a high radon content have been used for therapeutic
bathes for many centuries, e.g., in Ischia, Italy, over 2000 years ago, in Misasa,Japan,
for 800 years, and in several places in medieval Europe. After the discovery of radon,
its known balneological (bathing in water with high radon content) or
speliotherapeutic (inhalation of high-radon air - both summarized as balneology
here) applications started 1904 in Bad Kreuznach, Germany, and Bad Gastein,
Austria. The radon concentration in the waters varies widely. The strongest water
source ever was probably the "Bismarckquelle" in Schlema with about 40,000 Bq/
1, and currently is the "Wettinerquelle" in Bad Brambach with 26,000 Bq/l (for
Misasa, Japan, a value of 160,000 Bq/l, has been mentioned).
A typical inhalation source (Bad Gastein "Heilstollen") in which patients spend
six times half an hour during a 3-week treatment period (at a total cost of about
$500, i~suallypaid by the public health service) has approximately 40,000 Bq/m3 in
air. The radon is delivered to the patients primarily by inhalation for a prescribed
time in former mine shafts, or by bathing in radon water (with some of the radon
being lost between source and application). Obviously, modern radon balneology,
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as it developed during the last century primarily in Europe, has very little or nothing
to do with the popular fashion between approximately 1920 and 1940, also mainly
in Europe, of adding radium to many "healthy" food items, including drinking
water, crackers, chocolate (there is, for example, a German patent of 1934 for
adding radium bromide solution during the chocolate manufacturing process), and
even bed blankets in the U.K.
An interesting compilation of the earlier medical experience with low-dose
radium and radon ("emanation") treatments has been provided by Czech authors
around 1930 (Radium..., ca.1930). This booklet contains quotations from medical
journals as well as testimonies by individual physicians about positive health effects
due to external and internal radium/radon therapy for a multitude of diseases. One
of the authors of this booklet, P. Parchomenko, states that "it was found out that the
weak rays bring about characteristic biological effects, which as we know now are
one of the most important benefactors of nature... The effect of weak irradiation
differs greatly from that of the high activity of strong radon preparations."
There have also been many publications about modern radon balneology in
European journals (e.g., Falkenbach 1996), but only very few have been published
in English (e.g., Franke et al. 2000). Today, therapeutic radon centers (spas with
medical supervision of the treatment) are located (for further reviews see Pratzel
and Deetjen 1997; Deetjen and Falkenbach 1999; J6ckel 2001) in many countries
including
a Germany (Bad Brambach, Bad Kreuznach, Bad Miinster am Stein-

Ebernburg, Schlema, Sibyllenbad, Bad Steben)
a Austria (Bad Gastein, Bad Hofgastein, Bad Zell)

Chechia Uachimov/formerly Joachimsthal, Karlsbad)
France (Plombieres)
Italy (Ischia, Meran)
Ukraine (Chmelnk, Deneschi)
Russia (Pjatigorsk)
Japan (Misasa).
There are many other places that people visit for radon treatment, e.g., about
2000 people annually coming to several old uranium mines in a small town such as
the "Free Enterprise Health Mine" in Boulder, Colorado, U.S. (Singer 2001), where
even cats and dogs have been treated for age-related ailments, and some patients
returned for decades.
An interesting topic is radon therapy in the former Soviet Union, where such
treatments for a very wide spectrum of diseases was not restricted to natural radon
sources. Many hospitals produced radon from radium solutions. Thei-e has been
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some cooperation with German therapists (Andrejew 1992). A summary of the
Russian experiences is available in German (Legler 1993). Russian research on
radon balneology can be traced back to 1902, with a special role played by the
Governmental Balneological Institute in Pjatigorsk founded in 1920. There are
thousands of publications on radon therapy in the Russian literature, also dealing
with the dose-effect relationship, because the "artificial" radon dose could easily be
quantified and modified (K. Becker 2003, in press).
For example, in experiments with 148 patients, and radon concentrations between 1500 and 15,000 Bq/l in the 12 radon water bathes of 10 to 15 min each, very
good or good improvement in cervical pain syndrome have been observed among
55% of the patients (control group 25%), hut with side effects ("bathing reactions")
above 7500 Bq/l. Also with other painful diseases, optimal results have been obtained in the 1500 to 4500 Bq/l range (Strelkova et al. 1980). Various other Russian
authors confirmed this and similar observations. The techniques included injections and various local applications, and the indications ranged from heart and
neurological, gynecological, and skin diseases to gastritis and ulcers. Contraindications
were acute infections, psychic problems, pregnancy, malignant tumors, and tuberculosis.
Most of these indications are not considered for radon therapy nowadays in
Western Europe. Currently, about 75,000 patients are treated annually in German
and Austrian radon spas, mostly during a medically supervised 3-week period, for
which the public health system pays the costs (normally not only involving the
medical treatment, but also travel and accommodation). There are, however, also
many patients who take the treatments on their own expense, often repeatedly
because of the observed positive results.
Such effects have been categorized frequently as a variety of "traditional" medicine, similar to homeopathy, some herbal treatments, oriental practices, including
acupuncture and so on, with the benefits likely to be only or largely based on
psychological placebo effects without scientific basis. This situation changed substan tially in recent years due to:
1. several randomized chemical double-blind studies (known as the "gold standard of demonstrating medical effects"); and

2. accumulating experimental evidence that even the low total doses of radon
treatments (in the order of 1 to 5 mGy) have scientifically demonstrable
positive effects on the cellular and organism level.
The status has been summarized in two booklets (Schiittmann 1994, 1996)
published by the non-profit organization RADIZ (Radon Documentation and Information Center), Curiestr. 3, D-08301 Schlema, Germany. From this organization,
which was founded in 1992 by K. Aurand, also further radon-related booklets and
conference reports (in German) are available.
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A problem in the quantification of the pain-reducing effects is the fact that there
exists apparently no method yet for objectively measuring chronic pain. There are,
however, well-established methods such as the application of a defined pressure (in
kg/cm2) to pain-sensitive "tender points" (Figure 7), to which the patients respond
on a 0 to 10 scale between no and intolerable pain, or by measuring the backbone
flexibility in Morbus Bechterew patients from the distance between the back of the
head and a wall on which the patient is leaning. With a sufficient number of patients,
the reproducibility of such tests is rather good.

TENDER POINTS

1. M. levator scapulae
2. M. supraspinatus
3. M. teres minor
4. M. deltoideus
5. M. glutaeus maximus
6. M. glutaeus medius
7. M. bizeps femoris
8. M. semimembranosus

Figure 7.

Tender points used for testing the pressure pain sensitivity of patients with
rheumatic/arthritic problems. (Baumann 2003, Proceed. 3. Biophysikal.
Arbeitstagung Schlema 2001, registered with the German Libra~yin Frankfurt,
ISSN 1610-5079, used with permission of RADIZ.)
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With a bar code key, unknown to the patient and the medical staff, either radoncontaining or radon-free water of the same temperature, carbon dioxide content,
etc., is applied. While up to the end of the 3-week treatment the improvement, as
expressed in the pain threshold at pressure points, improves in both groups, the
positive long-term effect further increases during the 4month investigation period
in the radon group, but begins to disappear in the non-radon group (Figure 8).
There are, of course, inany different methods to express such and similar other
results (for a review representing the status of about 1996 regarding radon treatment of degenerative diseases of spine and joints, with 72 references, see Pratzel et
al. 1997).
A more current compilation of by now four completed radon double-blind
studies has been presented recently (Reiner 2001). It adds to the above study in
Schlema further results by Lind-Albrecht 1994; Reiner in Bad Brambach 1997;
Heisig in Bad Steben 1997; and Skorepa, also in Bad Steben, 1999. A typical result
is given in Figure 9 in which the beneficial effect (expressed as a "complex parameter") is given for rheumatic arthritis patients at the end of the treatment, 3 and 6
months after treatment. The results of these and other studies are in progress. In
Figure 10, a summary of all studies is presented, with the 95 % confidence limits for
short-term, middle-term, and long-term effects (values below zero indicate positive
effects). Further studies are in progress, including radon inhalation in Bad Gastein

Cervical spondylosis
Tender point measurement
Pressure threshold kglqcm

.................................................

&RADON WATER BATHS

initid value

Figure 8.

1st week

2nd week

'

3rd week

2nd month

4th month
40

Tender point measurements of pain threshold with cervical spondylosispatients
during, and after the end of the treatment with Rn and placebo tap water (note
change of time scale at end of treatment). (Reproducedfrom Pratzel et al. 1997,
used with permission of ISMH.)
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3 Monate

Radon-Gruppe

6 Mqnate

Kontrollgruppe

I

A complex "painless parameter" comparing in a study the radon and the control
group at the end of the treatment period (left) with the effects 3 months
(middle) and 6 months (right) after the treatment; radon group black, controls
light. (Reiner 2003, Proceed. 3. Biophysikal. Arbeitstagung Schlema 2001, registered with the German Library in Frankfurt, ISSN 1610-5079, used with permission of RADIZ.)

in which the results, with Dutch patients, look promising (Falkenbach 2001). It
seems that approx. 40,000 Bq/m3 represent the lower limit for successful inhalation
treatments.
The mechanism of the biopositive radon effects is still not clear and subject to
intense research. More general explanations such as stimulation of the immune
system (e.g., Soto 1997) have been replaced by detailed investigations such as the
influence on the Langerhans cells, an increase in the encephalin level, reduction of
oxygen radicals in the neutrophiles and macrophages, influences on homoeostasis,
factors influencing the attachment of leukocytes atjoint tissues, and so on. One of
the most recent publications deals with the long-lasting radon progeny activity on
skin and hair after speliotherapeutic radon exposures in Bad Gastein (Falkenbach
et al. 2002). They found surprisingly high adhesive properties of radon daughters,
thus extending the period of possible biopositive effects on Langerhans cells, and
perhaps systemic effects mediated by their alteration.
Unlike the successful treatment of non-malignant inflammatory diseases with
local external X or gamma radiation in a fractionated 3 to 6 Gy treatment, which is
currently used on about 20,000 patients annually just in Germany, the doses due to
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Stand ardisierte Mittelwertdflerenz
mit 95% Konfidenzintervall
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Figure 10.

Vergleich rnit Kontrollgruppe
Vergleich mit unbehandelter Gruppe

Summary of the pain-reducing effects of four randomized double-blind radon
studies between 1993 and 1997, showing in comparison with the control groups
(bars indicating the 95 % confidence limits) the short-term effects (upper thud),
mid-term (middle), and long-term (lower part) effects; summary of a l l studies
bottom line. (Reiner 2003, Proceed. 3. Biophysikal. Arbeitstagr~ngSchlema
2001, registered with the German Library in Frankfurt, ISSN 1610-5079, used
with permission of RADIZ.)
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radon inhalation or through the skin by bathing in radon water are very low. As
demonstrated in measurements of the radon exhalation rate of persons submersed
in radon water and other studies, the half-life of radon in the body is short (in the
order of a few hours). It accumulates in certain fatty tissues, and the effective wholebody dose is only in the range of a few mGy (see, for example, Tempfer et al. 2002).
It should be noted that the conventional treatment of arthritic and rheumatic
diseases with nonsteroid antirheumatics (such as aspirin and diclophenac) have
serious side effects, leading to the estimated death of about 2000 persons annually
in Germany, and 12,400 in the U.S. On the other hand, no lethal side effect of radon
balneology has ever been reported (Jcickel2001).Despite large-scale and expensive
efforts by the Genrlan authorities (ca. $2000 million) to measure and reduce the
population exposure to radon (Becker 1996), the Federal Institute of Radiatioil
Protection now "tolerates" therapeutic radon treatments, with a few exceptions such
as children and pregnant women. In the Gernlan media, there have been various TV
and radio specials as well as articles discussing radon therapy (Test 1999).
The persons professionally active in the treatment facilities are ~l~~ssifietl
1
's
radiation workers and subject to personnel monitoring. They receive a close of ,tl)o~rt
8 to 15 mSv/y, based on the current ICRP models assuming a biological efferti\t.llt.sj
(RBE) of 20 for alpha and other high-LET (e.g., neutron) radiation. There is by n o w
general agreement among the experts that the RBE should be reduced to about 5
to 10, with some careful inhalation studies for lung cancer induction in animals in
England, indicating values as low as 2 (Kellington 1997).

TRENDS AND CONCLUSIONS
Most research on radon effects in Western Europe suffers from a biased antiradon attitude, essentially equating residential radon coilceiltrations with a health
risk based on the ICRP, BEIR VI, and other "official" statements. They are strongly
influenced by the situation in the U.S., and the studies and recommendations of
international, regional, and national governmental and nongoverninental bodies
that are closely interconnected. The more important ones are ICRP, UNSCEAR,
IAEA, EU, as well as NCRP and EPA in the U.S. This is reflected in governmental
support for "anti-radon" research and epidemiological studies of controversial quality. The situation has been described by many authors (for example, Proctor 1995):
"If the politics of science consist in the structure of priorities, then it is important
what gets studied and why, and what not gets studied and why not. One has... to
study the social construction of ignorance. The persistence of controversy is often
not a natural consequence of imperfect knowledge but a political consequence of
conflicting interests and structural apathies. Controversy can be engineered; igncrance and uncertainty can be manufactured, maintained, and disseminated." This
describes what happened in many countries in Central Europe. For example, a
"German Radon Study" on residential radon epidemiology has been supported at
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the level of about $8 million by the Ministry of Environment (Wichmann et al. 1998,
1999), but other studies questioning the official LNT radon hypothesis (such as
Conrady et al. 2000), as well as those on radon balneology research, did not receive
any governmental support.
It is interesting to note that in all countries, despite substantial "educational"
efforts to promote residential radon remediation, there has been a remarkable
reluctance of people to react to governmental warnings and advice, in particular
when private funding of such activities is involved. An increasing number of people
ill high-radon areas even refuse the free-ofcharge radon monitoring of their homes.
Assuming an EU limit of 200 Bq/m3 in homes, in Germany 200,000 residences
involving about 800,000 persons would require remedial action. Radon reduction
costs currently vary between $2,500 and $25,000, with up to $130,000 for an old
house in Austria. There are lower predictions for the future, but new radonreducing regulations would certainly increase construction costs, in particular because new energy-preservation regulations require better thermal insulation that
imply less ventilation of homes, known to increase residential radon levels.
Obviously, miner's data cannot be extrapolated to residential radon situations,
the dose-rate effect is substantial, and the uncertainties of retrospective smoking
dosimetry dominate by far those of retrospective radon dosimetry, as -with a risk
rate of 10 to 20 - the "error" in the number of cigarettes smoked in the past far
exceeds the risk attributed to radon. Serious cost/benefit assessment of the radon
issue would lead to a number of basic ethical questions, for example, How much of
the limited funds should a society devote to the further reduction of hypothetical
risks such as residential radon? If they exist at all, they are certainly minor compared
to other, real and demonstrable environmental and health risks in affluent, and
even more so in less affluent, societies - keeping in mind that the daily income of
about half of nlankind amounts to <$2.
Because of the omnipresence of radon, its (officially claimed) large contribution
to total population dose, and the wide fluctuation in concentration in different
areas of the world depending on soil composition, construction materials, and other
factors, it should be considered an important test for the validity of the LNT
hypothesis, and the regulatory measures related to it. This topic thus also relates to
areas such as waste management, decommissioning of nuclear facilities, public
acceptance of nuclear energy, and other issues. So far, most of the more recent data
indicate (despite the well-known difficulties with low-dose epidemiology) that for
radon, delivering relatively large local doses at high-LET and low dose rate, the same
basic dose-response diagram applies as for other radiation effects on organisms
(Figure 11). Radon thus provides important further evidence against the LNT
hypothesis, and if a threshold is needed at all, it should be around 500 to 1000 Bq/
ni3 (Becker 2002), and not 148 to 400 Bq/m3 as currently suggested by various
national and international bodies.
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Figure 9.

Schematical diagram of the biopositive and bionegative radiation effects as a
function of dose, with the damage induction superimposed by the biological
defense mechanism, with a de facto threshold generally in the area between 0.2
and 2 Gy (Becker 2002, after Feinendegen).
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